Pfizer seeks FDA authorization for COVID-19 pill

Nov. 16, 2021 2:15 PM ETPfizer Inc. (PFE)MRKBy: Dulan Lokuwithana, SA News Editor32 Comments

Exterior view of Pfizer Pharmaceutical company"s offices in Brussels, Belgium

Alexandros Michailidis/iStock Editorial via Getty Images

  • Pfizer (PFE +0.6%) has sought the FDA’s Emergency Use Authorization (EUA) for PAXLOVID (PF-07321332; ritonavir) for mild to moderate COVID-19 in patients who are at a higher risk of hospitalization or

Recommended For You

Comments (32)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.